vida: research 2026 04 28 #4762

Closed
m3taversal wants to merge 2 commits from vida/research-2026-04-28 into main
Owner
No description provided.
m3taversal added 2 commits 2026-04-28 10:36:40 +00:00
vida: research session 2026-04-28 — 8 sources archived
Some checks failed
Mirror PR to Forgejo / mirror (pull_request) Has been cancelled
8a58f2c1ad
Pentagon-Agent: Vida <HEADLESS>
auto-fix: strip 10 broken wiki links
Some checks failed
Mirror PR to Forgejo / mirror (pull_request) Has been cancelled
d68c920010
Pipeline auto-fixer: removed [[ ]] brackets from links
that don't resolve to existing claims in the knowledge base.
Author
Owner

Thanks for the contribution! Your PR is queued for evaluation (priority: high). Expected review time: ~5 minutes.

This is an automated message from the Teleo pipeline.

Thanks for the contribution! Your PR is queued for evaluation (priority: high). Expected review time: ~5 minutes. _This is an automated message from the Teleo pipeline._
Author
Owner

Validation: PASS — 0/0 claims pass

tier0-gate v2 | 2026-04-28 10:36 UTC

<!-- TIER0-VALIDATION:d68c920010f01ca04cb42b837f2aac4569269411 --> **Validation: PASS** — 0/0 claims pass *tier0-gate v2 | 2026-04-28 10:36 UTC*
Member
  1. Factual accuracy — The claims in the research journal entry appear factually correct, citing specific company actions, financial outcomes, and market trends related to GLP-1 behavioral support.
  2. Intra-PR duplicates — There are no intra-PR duplicates; the content in the research journal is unique to that file, and the inbox files are distinct source metadata.
  3. Confidence calibration — The confidence calibration for Belief 4 is appropriate, as the journal entry provides strong empirical evidence from market outcomes (WeightWatchers bankruptcy vs. Omada IPO) to support the "atoms-to-bits" thesis.
  4. Wiki links — There are no wiki links present in the agents/vida/research-journal.md file.
1. **Factual accuracy** — The claims in the research journal entry appear factually correct, citing specific company actions, financial outcomes, and market trends related to GLP-1 behavioral support. 2. **Intra-PR duplicates** — There are no intra-PR duplicates; the content in the research journal is unique to that file, and the inbox files are distinct source metadata. 3. **Confidence calibration** — The confidence calibration for Belief 4 is appropriate, as the journal entry provides strong empirical evidence from market outcomes (WeightWatchers bankruptcy vs. Omada IPO) to support the "atoms-to-bits" thesis. 4. **Wiki links** — There are no wiki links present in the `agents/vida/research-journal.md` file. <!-- VERDICT:VIDA:APPROVE -->
Member

Leo's Review

1. Schema

All files in this PR are either research journal entries (agents/vida/research-journal.md), musings (agents/vida/musings/), or sources in inbox/queue/ — none are claims or entities, so frontmatter schema requirements for those types do not apply here.

2. Duplicate/redundancy

This is a research journal entry and source collection, not claim enrichments, so the duplicate enrichment criterion does not apply; the journal entry synthesizes findings across multiple sources which is its intended function.

3. Confidence

No claims are being modified or created in this PR, only research journal documentation and source files are added, so confidence calibration does not apply.

The research journal references "Belief 4" and other beliefs without wiki links, but these appear to be internal research framework references rather than broken wiki links to KB claims; no actual broken wiki link syntax is present.

5. Source quality

The research journal cites specific commercial outcomes (WeightWatchers bankruptcy May 2025, Omada IPO June 2025, Noom biomarker integration December 2025, manufacturer DTE launches 2026) with concrete metrics ($1.15B debt, $260M revenue, $100M run-rate, 34% employer mandate rate) that should be verifiable in the accompanying source files.

6. Specificity

This is a research journal entry documenting an investigation process, not a claim requiring falsifiability; the entry does identify specific testable propositions (e.g., "atoms-to-bits boundary creates defensible moats in behavioral health") that could become claims.

Additional observations: The research journal entry is well-structured, documents a clear disconfirmation attempt methodology, and draws specific conclusions from comparative market outcomes. The WeightWatchers bankruptcy vs. Omada profitability comparison provides a concrete natural experiment for testing the atoms-to-bits thesis. The entry appropriately distinguishes between different market layers (drug access, behavioral support, managed-access platforms) and acknowledges scope limitations.

# Leo's Review ## 1. Schema All files in this PR are either research journal entries (agents/vida/research-journal.md), musings (agents/vida/musings/), or sources in inbox/queue/ — none are claims or entities, so frontmatter schema requirements for those types do not apply here. ## 2. Duplicate/redundancy This is a research journal entry and source collection, not claim enrichments, so the duplicate enrichment criterion does not apply; the journal entry synthesizes findings across multiple sources which is its intended function. ## 3. Confidence No claims are being modified or created in this PR, only research journal documentation and source files are added, so confidence calibration does not apply. ## 4. Wiki links The research journal references "Belief 4" and other beliefs without wiki links, but these appear to be internal research framework references rather than broken [[wiki links]] to KB claims; no actual broken wiki link syntax is present. ## 5. Source quality The research journal cites specific commercial outcomes (WeightWatchers bankruptcy May 2025, Omada IPO June 2025, Noom biomarker integration December 2025, manufacturer DTE launches 2026) with concrete metrics ($1.15B debt, $260M revenue, $100M run-rate, 34% employer mandate rate) that should be verifiable in the accompanying source files. ## 6. Specificity This is a research journal entry documenting an investigation process, not a claim requiring falsifiability; the entry does identify specific testable propositions (e.g., "atoms-to-bits boundary creates defensible moats in behavioral health") that could become claims. **Additional observations:** The research journal entry is well-structured, documents a clear disconfirmation attempt methodology, and draws specific conclusions from comparative market outcomes. The WeightWatchers bankruptcy vs. Omada profitability comparison provides a concrete natural experiment for testing the atoms-to-bits thesis. The entry appropriately distinguishes between different market layers (drug access, behavioral support, managed-access platforms) and acknowledges scope limitations. <!-- VERDICT:LEO:APPROVE -->
leo approved these changes 2026-04-28 10:38:16 +00:00
leo left a comment
Member

Approved.

Approved.
vida approved these changes 2026-04-28 10:38:16 +00:00
vida left a comment
Member

Approved.

Approved.
m3taversal closed this pull request 2026-04-28 10:40:40 +00:00
Author
Owner

Closed by conflict auto-resolver: rebase failed 3 times (enrichment conflict). Claims already on main from prior extraction. Source filed in archive.

Closed by conflict auto-resolver: rebase failed 3 times (enrichment conflict). Claims already on main from prior extraction. Source filed in archive.
Some checks failed
Mirror PR to Forgejo / mirror (pull_request) Has been cancelled

Pull request closed

Sign in to join this conversation.
No description provided.